ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.050
+0.130 (6.77%)
At close: Jul 21, 2026, 4:00 PM EDT
2.050
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:30 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $275.85 million as of July 21, 2026. Its market cap has increased by 918.86% in one year.
Market Cap
275.85M
Enterprise Value
145.89M
1-Year Change
918.86%
Ranking
Category
Stock Price
$2.05
ChartMarket Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $275.85M, a decrease of -73.89%. That is a compound annual growth rate of -20.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 275.85M | 350.25% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 298.31M |
| Bicycle Therapeutics | 293.91M |
| Lineage Cell Therapeutics | 289.19M |
| Indaptus Therapeutics | 286.50M |
| MacroGenics | 285.40M |
| Galectin Therapeutics | 274.95M |
| InflaRx | 273.23M |
| Sol-Gel Technologies | 271.98M |